RecruitingNot ApplicableNCT07202507

Proof-of-Concept Study of the SNOEZELEN Device on Anxiety Symptoms in Patients Hospitalized for Chemotherapy in a Pediatric Oncology Department


Sponsor

Centre Oscar Lambret

Enrollment

20 participants

Start Date

Sep 1, 2027

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to evaluate whether the Snoezelen multisensory relaxation approach can reduce anxiety symptoms in children and adolescents aged 8 to 17 years hospitalized for chemotherapy in a pediatric oncology unit. Researchers will compare patients' symptoms during a chemotherapy cycle with Snoezelen sessions to a previous cycle without Snoezelen, in order to assess changes in psychological and physical well-being. Participants will: * Be enrolled between their first (without Snoezelen) and second (with Snoezelen) chemotherapy cycles * Complete self-report questionnaires on anxiety, depression, quality of life, and nausea * Receive 45-minute Snoezelen sessions every two days during their second hospitalization * Participate in a semi-structured interview after the final session * Provide data on medications (anxiolytics, antiemetics) and vomiting frequency during both hospitalizations


Eligibility

Min Age: 8 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a sensory relaxation room called a Snoezelen — which uses gentle lights, sounds, textures, and calming environments — can help reduce anxiety in children and teenagers who are in the hospital receiving chemotherapy for cancer. The goal is to find a non-medication approach to managing treatment-related stress. **You may be eligible if...** - You are between 8 and 17 years old - You are a new patient being treated for any type of cancer at the participating hospital in France - You are staying in the hospital for several days for chemotherapy - You (and your parent or guardian) speak French and agree to participate - You have valid social security coverage **You may NOT be eligible if...** - You have claustrophobia or would feel distressed in a small enclosed room - You have psychiatric, cognitive, or addiction issues that would prevent you from following the study - You are too unwell (severe fatigue or symptoms not responding to treatment) to participate - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERself-report questionnaires, research interviews

self-report questionnaires and research interviews


Locations(1)

Centre Oscar Lambret

Lille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07202507


Related Trials